KATHERINE MCNAMARA: Open Payments
NPI 1962167858 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 12 payments from 10 companies in 2025. Trend: 2023 $78 · 2024 $321 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $101 |
| Amgen Inc. | 1 | $63 |
| TerSera Therapeutics LLC | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Lundbeck LLC | 2 | $31 |
| ABBVIE INC. | 1 | $25 |
| GENZYME CORPORATION | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $14 |
Products named: TREMFYA, TEPEZZA, Quzyttir, LUTATHERA, VYEPTI, SKYRIZI, FABRAZYME, NUCALA.
Industry payments across MO — which companies pay providers there.
